SCHEMBL18949100

SCHEMBL18949100

CCCC(CCC)C(=O)c1ccccn1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 1/20 0.56
ALDH1A1 P00352 2/20 0.52
CES2 O00748 1/20 0.50
CES1 P23141 1/20 0.50
LMNA P02545 5/20 0.48
L3MBTL1 Q9Y468 3/20 0.48
NAPRT Q6XQN6 1/20 0.48
P4HTM Q9NXG6 1/20 0.48
KMT2A Q03164 1/20 0.44
EPHX2 P34913 1/20 0.44
KDM4E B2RXH2 5/20 0.44
HTT P42858 4/20 0.44
SMN1; SMN2 Q16637 3/20 0.43
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
PKM P14618 2/20 0.43
MITF O75030 1/20 0.43
GRM4 Q14833 1/20 0.43
CTNNB1 P35222 1/20 0.43
WNT3A P56704 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21499104 0.93 GSK3B (0.53) GSK3BALDH1A1CES2CES1LMNA
SCHEMBL19364775 0.87 LMNA (0.51) GSK3BALDH1A1CES2CES1LMNA
SCHEMBL19333994 0.86 GSK3B (0.59) GSK3BALDH1A1CES2CES1LMNA
SCHEMBL14917318 0.85 GSK3B (0.45) GSK3BALDH1A1CES2CES1LMNA
SCHEMBL14917319 0.85 GSK3B (0.45) GSK3BALDH1A1CES2CES1LMNA
SCHEMBL19186112 0.85 GSK3B (0.54) GSK3BALDH1A1CES2CES1LMNA
2-Picolinic Acid SCHEMBL28281361 0.78 LMNA (0.67) GSK3BALDH1A1CES2CES1LMNA
SCHEMBL8696894 0.78 GSK3B (0.50) GSK3BALDH1A1CES2CES1LMNA
SCHEMBL9658047 0.78 GSK3B (0.50) GSK3BALDH1A1CES2CES1LMNA
SCHEMBL7277861 0.77 GSK3B (0.58) GSK3BALDH1A1CES2CES1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9676802-B2 Hepatitis C virus inhibitors ENANTA PHARMACEUTICALS, INC. (US) 2017-06-13 US disclosed